Available for order review
PEPTAS research material
LL-37 5mg
LL-37 5mg research material identified as a 37-residue peptide sequence and limited to qualified laboratory use.
Volume pricing for research orders:
3–5 units: $58.50/unit (10% off) · 6–9 units: $55.25/unit (15% off) · 10+ units: $48.75/unit (25% off)
Need a document before ordering?
Request product or batch information.
Technical and procurement context
Product information
PEPTAS catalog record
About LL-37 5mg
LL-37 is a 37-residue peptide sequence associated with the human cathelicidin research literature. Full-length LL-37 should be distinguished from fragments, modified analogs, and related sequences. The catalog name therefore needs to be read together with the sequence and analytical information for the actual item.
PEPTAS lists this 5mg material for lawful professional research only. The listing does not make antimicrobial, diagnostic, therapeutic, safety, or performance claims, and it must not be interpreted as permission or guidance for any human, veterinary, household, or environmental application.
- Catalog item
- LL-37 5mg
- Listed amount
- 5mg
- Material class
- Thirty-seven-residue peptide research material
- Permitted context
- Qualified laboratory research only
Chemical identity
- CAS registry number
- 154947-66-7
- Molecular formula
- C205H340N60O53
- Purity stated on packaging
- ≥ 98.8% (HPLC)
Free-acid composition; the counterion is confirmed for the accepted order.
These identifiers describe the catalog material. The purity figure above is the specification printed on the packaging, not a result for any particular lot — batch-specific analytical documentation is confirmed for the actual item or accepted order. See Quality control.
Planning work with this material
Studies involving a charged, relatively long peptide may be sensitive to preparation conditions, surfaces, containers, and analytical technique. The laboratory must define and validate those controls; PEPTAS does not provide an experimental protocol through the product page.
Confirm sequence, termini, counterion, available analytical records, and written storage information before ordering. On arrival, record package condition and lot details and quarantine any item that does not match the accepted documentation.
Documentation and order review
Availability, product identity, listed quantity, price, packaging, transport terms, storage information, and any supporting analytical documents are confirmed for the actual item or accepted order. Request the information your project requires before purchasing; a general catalog page cannot replace an order-specific specification or certificate.
- Confirm purchaser eligibility, destination rules, permits, and institutional approvals.
- Define identity and analytical acceptance criteria before the material is received.
- Inspect the package, identifier, quantity, lot information, and documents on arrival.
- Maintain controlled access, storage, preparation, traceability, and disposal records.
Research-use conditions
Not for human or veterinary use. This material is not a medicine, food, dietary supplement, cosmetic, diagnostic product, or household product. It must not be administered, consumed, compounded for administration, used for self-experimentation, or represented as suitable for the diagnosis, treatment, mitigation, cure, or prevention of any condition.
Purchasers are responsible for lawful acquisition and use, competent risk assessment, suitable facilities and personnel, appropriate personal protective equipment, validated procedures, security, incident response, and waste disposal. Website information is not medical, veterinary, legal, regulatory, or scientific-protocol advice.
Continue catalog review
